Main Article Content
Currently, with introduction of vaccination against epidemic parotitis, differential diagnosis of salivary gland involvement in children should include other viruses, such as cytomegalovirus, Coxsackie virus, herpes virus type 6, human T-lymphotropic virus, human immunodeficiency virus, etc., as well as autoimmune and oncologic diseases. Comprehensive differential diagnosis is required before establishing the diagnosis of exclusion, such as juvenile recurrent parotitis. It will ensure more effective therapeutic approach and avoiding the prescription of unnecessary medicines and manipulations. The article presents detailed clinical case of recurrent parotitis in a fully vaccinated (according to national vaccination schedule) 6-year-old boy, who experienced several episodes of painless swelling of the left parotid area without fever or with low-grade fever accompanied by redness in the left eye during observation. Performed laboratory survey and instrumental examination are given. Methods and efficacy of therapeutic approach are described. The article presents etiological classification of salivary gland involvement, which includes inflammatory diseases, autoimmune and hypertrophic lesions, obstructive and traumatic conditions, developmental defects, tumors. Epidemiologic and etiologic features of parotitis in pediatric population are considered. Differential diagnosis also includes, for example, Sjogren’s syndrome, sarcoidosis, cat-scratch disease, Parinaud conjunctivitis, with description of diagnostic criteria of the mentioned conditions. According to clinicians, juvenile recurrent parotitis was diagnosed in the presented case. The article presents epidemiological features of this pathology, diagnostic criteria, discussion of possible etiology, recommendations for the management. Necessity and safety of vaccination against epidemic parotitis were accentuated, as well as importance of avoiding the prescription of unnecessary medicines. Vaccination against epidemic parotitis is a prerequisite for the prevention of viral lesions of the salivary glands. It also helps to narrow the differential diagnosis of parotitis causes. If diagnosis of epidemic parotitis is excluded in a child, comprehensive clinical, laboratory and instrumental examination is recommended. It is very important to provide follow-up after the first episode of parotitis in order to exclude recurrent course of the disease. In the presence of recurrent parotitis and exclusion of other causes of damage to the parotid salivary gland, it should be suggested that the child has juvenile recurrent parotitis, which is a diagnosis of exclusion, and can be made after at least 12 months of follow-up. The drug management of juvenile recurrent parotitis should exclude unreasonable prescription of medicines, such as antibiotics, antiviral drugs and especially immunomodulators. Only symptomatic therapy is indicated, providing relief of symptoms. Systematic follow-up of patients with this pathology is required.
How to Cite
Mavrutenkov, V., Z. Chykarenko, and N. Zhukova. “Clinical Case of Recurrent Parotitis in a Child. Discussion of Causes”. CHILD`S HEALTH, vol. 13, no. 3, June 2018, pp. 311-6, doi:10.22141/2224-05188.8.131.528.132914.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.